HG
Honkote Ganesh Malathi
About Honkote Ganesh Malathi
Data last updated:
Honkote Ganesh Malathi has 17 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Estima Pharmaceuticals Private Limited and Curion Pharmaceuticals Private Limited. Formerly with 2 companies. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Estima Pharmaceuticals Private Limited U24299KA2022PTC159912 | Director | 11 Apr 2022 | 2022 | Active |
| Estima Pharma Solutions Llp AAB-0780 | Designated Partner | 23 Aug 2012 | 2012 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Curion Pharmaceuticals Private Limited U51101KA2012PTC064705 | Director | 03 Jul 2012 | 2012 | Strike Off |
| Amogha Pharma & Clinical Research Private Limited U73100KA2009PTC049412 | Director | 30 Jun 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Honkote Ganesh Malathi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Honkote Ganesh Malathi
Honkote Ganesh Malathi has 17 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Estima Pharmaceuticals Private Limited and Curion Pharmaceuticals Private Limited. Formerly with 2 companies. Engaged in General Business. Contributes to corporate operations.
Honkote Ganesh Malathi is associated with 2 companies as Director and Designated Partner.
Honkote Ganesh Malathi has expertise in General Business.
Honkote Ganesh Malathi has 17 years in corporate governance.